AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹78 Cr | ₹76 Cr | ₹71 Cr | ₹72 Cr | ₹77 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AARTI DRUGS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹76 Cr |
| Mar2023 | ₹71 Cr |
| Mar2022 | ₹72 Cr |
| Mar2021 | ₹77 Cr |
How is Deferred Tax Assets / Liabilities of AARTI DRUGS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹78 Cr | 3.34 | |
| Mar2024 | ₹76 Cr | 6.68 | |
| Mar2023 | ₹71 Cr | -2.02 | |
| Mar2022 | ₹72 Cr | -6.10 | |
| Mar2021 | ₹77 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,801.3 Cr | 2.3% | 5.2% | -18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 2.3% |
5.2% |
-18.9% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses